Electronics & Pharma Secure 70% of FY25 PLI Funds: Govt Data
The Production Linked Incentive (PLI) scheme, launched by the Indian government in 2021, has been instrumental in boosting domestic manufacturing in various sectors. The scheme was initially rolled out for 14 key sectors, including electronics, pharmaceuticals, automobiles, and textiles, among others. As per the latest data, the electronics and pharma sectors have emerged as the top beneficiaries of the scheme, accounting for nearly 70% of the total funds disbursed in Financial Year (FY) 2025.
According to official data, the electronics sector received ₹5,732 crore, while the pharma sector got ₹2,328 crore. These figures are significant, considering that the total amount disbursed under the PLI scheme during FY25 stood at ₹10,114 crore. This means that the electronics and pharma sectors have secured a substantial portion of the total funds allocated for the scheme.
The PLI scheme aims to promote domestic manufacturing by providing incentives to companies that invest in new projects or expand existing ones. The scheme is designed to encourage companies to increase their production capacity, improve their research and development capabilities, and increase their exports.
The data released by the government highlights the importance of the electronics and pharma sectors in India’s economy. These sectors have been growing rapidly over the years, driven by factors such as increasing demand for electronic goods, growth in the pharmaceutical industry, and the country’s focus on developing a robust healthcare infrastructure.
The electronics sector has been a key driver of growth in India’s manufacturing sector. The sector has seen significant investments in recent years, driven by the government’s initiatives to promote domestic manufacturing. The PLI scheme has been instrumental in attracting new investments in the sector, with many global companies setting up manufacturing facilities in India.
The pharma sector has also been growing rapidly, driven by the country’s increasing focus on healthcare. The sector has seen significant investments in recent years, driven by the government’s initiatives to promote domestic manufacturing and reduce dependence on imports.
The PLI scheme has been successful in attracting new investments in the pharma sector, with many companies setting up manufacturing facilities in India. The scheme has also helped to increase exports of pharmaceutical products, which has been a key focus area for the government.
The data released by the government also highlights the importance of the PLI scheme in promoting domestic manufacturing. The scheme has been instrumental in increasing the production capacity of companies, improving their research and development capabilities, and increasing their exports. The scheme has also helped to create new jobs and increase the income of people involved in the manufacturing sector.
In conclusion, the data released by the government highlights the importance of the electronics and pharma sectors in India’s economy. These sectors have been growing rapidly over the years, driven by factors such as increasing demand for electronic goods, growth in the pharmaceutical industry, and the country’s focus on developing a robust healthcare infrastructure. The PLI scheme has been instrumental in attracting new investments in these sectors, increasing their production capacity, improving their research and development capabilities, and increasing their exports.
Source:
